Berkeley HeartLab adopts GenTegra DNA to support diagnostic genetic testing for cardiovascular disease (News-Medical-Net)
GenVault Corporation today announced that Berkeley HeartLab, a subsidiary of Celera Corporation, has adopted GenTegra DNA to preserve and store diagnostic samples for genetic testing related to the management of cardiovascular disease.